INTRODUCTION
T he NHS Breast Screening Programme (NHSBSP) was set up in 1988 to invite women aged 50-64 for breast screening once every three years, with women older than 64 being encouraged to self-refer. 1 Following the publication of the NHS Cancer Plan in 2000, 2 the programme has been extended to invite women up to the age of 70. Regional breast screening quality assurance reference centres (QARCs) monitor the performance of individual screening units against national standards. However, these standards only relate to screen-detected cancers, which represent around 20% of the total breast cancers in the eligible population (West Midlands Cancer Intelligence Unit, personal communication). To determine the impact of screening on the whole population, information on the screening history of all women with breast cancer is required.
This paper describes a practical method for assigning a screening status to every histologically or cytologically confirmed primary malignant (invasive and in situ) breast cancer diagnosed in the West Midlands health region, from the start of screening on 1 March 1988 to 31 March 2001. The method relies upon automatic and manual algorithms to match cases held on the West Midlands Cancer Intelligence Unit's (WMCIU) cancer registration database and those recorded on the computer systems in each breast screening unit. In the West Midlands, the QARC is part of the WMCIU. All West Midlands breast screening units use the National Breast Screening System (NBSS) to record data. 3 Although the procedures described refer to the NBSS and the WMCIU's cancer registration database, the methodology could be applied to other computerized or paperbased systems. The method provides an accurate insight into the number of interval cancers diagnosed in the West Midlands, since the screening programme began. Addition-ally, it identifies those cases diagnosed in women who did not accept their invitation for screening. By mapping the relative proportions of women assigned to each screening status, survival profiles of the population can be derived to provide a measurement of the efficacy and impact of screening.
METHODS

Identifying screen-detected cancers
The breast screening units in the West Midlands opened between 1 March 1988 and 10 June 1991, with each unit taking three to four years to reach full coverage of women aged 50-64. Screen-detected breast cancers were identified at each screening unit by running a bespoke query on the NBSS. The query identified demographic details and the date on which the mammogram was reported at the screening unit. This ensured that the screen-detected cancer was matched with the correct tumour at the WMCIU. The screening unit identifier (Sx number), whether the episode related to a prevalent (first time) or incident (subsequent) screen, and tumour characteristics were also extracted from the NBSS.
Matching cases against the WMCIU's cancer registration database
An extract was obtained from the WMCIU's cancer registration database containing all breast cancers (ICD10 C50 [invasive] or D05 [in situ]) diagnosed in the period 1 March 1988-31 March 2001 in women aged 50-68 at the time of their diagnosis. The key data items extracted were diagnosis date, birth date, current name, current address and postcode, diagnosis postcode and NHS number. A woman was considered eligible for screening if the breast screening unit serving her postcode had started screening at the time her cancer was diagnosed. This ensures that screening status data can be analysed at screening service level. Women were initially allocated to a screening unit on the basis of this postcode. Where no postcode was available, a screening unit was allocated based on any address details or information concerning hospital of treatment. A cut-off age of 68 was chosen to allow the identification of interval cancers diagnosed in women after their last screening appointment aged 64.
Assigning a screening history
In summary, the methodology began by creating a table in Microsoft Access to hold all data for the matched cohort of cases. Each primary breast cancer that was not already classified as screen-detected was looked up on the NBSS. When a match was found, the case was assigned to a screening unit (usually, but not necessarily, the unit originally allocated on the basis of postcode) and, using the screening status algorthim in Figure 1 , allocated to one of the eight mutually independent screening status categories described in Table 1 . In addition to the usual classifications (screen-detected, interval cancer, nonattender and lapsed attender) four more classifications were created -diagnosed before invitation, assessment defaulter, not screened -ceased, and not screened -not known to the NHSBSP.
Multiple primaries
The screening status table contained one record for each tumour and, for the purpose of the study, only the primary breast cancer was included. For multiple primary tumours, the tumour of most prognostic significance according to the Nottingham Prognostic Index (NPI) was included. In the absence of an NPI score, grade and/or size was used to establish the most significant tumour. Multiple primary tumours were defined as two tumours diagnosed in different breasts, or in the same breast but with different histologies.
Resolving duplicates and checking for new cases
Once the screening status table was complete, a search was performed for cases with duplicate screening unit identifiers or NHS numbers. Multiple primaries and recurrences had already been flagged. Cases on the cancer registration database which had been cancelled since the original extract was provided as part of routine data quality procedures, were identified and excluded. Other duplicates suggested by this process (name spellings, addresses, etc) were passed to the cancer registration data quality team for resolution.
Exceptions to the rule
In rare cases where a woman was diagnosed outside of the NHSBSP on the screening invitation date, the correct dates were recorded but the screening status was assigned as if diagnosis was the day after invitation. This rule ensured that any incidence of histologically or cytologically confirmed primary breast cancer which could be matched to a complete record at the WMCIU, and which agreed with a complete set of episodes and appointments within the NHSBSP, could be assigned one of the eight mutually independent categories. Where a record was found on the NBSS around the time of diagnosis but where it was not sufficient to determine a screening status, the case was flagged as an unresolvable query. There were 471 such cases. Cases where a screening status could not be applied because of anomalous or missing information from the cancer registration database were passed to the cancer registration data quality team for resolution. These included cases where the diagnosis date was incomplete and cases which appeared on NBSS as benign lesions but on the cancer registration database as malignant.
In some cases, the NBSS record from the screening unit serving the diagnosis postcode indicated that the woman had been previously screened at another NHSBSP screening unit or had moved to another screening unit catchment area around the time of diagnosis. These cases were manually looked up on the NHS Information Authority (NHSIA) Exeter System (a call/recall register used in England and Wales for the administration of all cancer screening call/ recall programmes) in order to locate the correct screening unit. Cases where the relevant invitation (the invitation before diagnosis or the first invitation after diagnosis) was outside the West Midlands, where the woman normally lived outside the region but was attending a West Midlands hospital, and where the postcode recorded on the cancer registration database appeared to be a West Midlands case but the address, general practitioner (GP) or cancer registry record was outside the region were all flagged as unresolvable. There were 164 such cases.
Women who were on a call/recall register in the West Midlands, but had no breast screening record at any of the nine breast screening units were given the screening status 'Not screened -not known to the NHSBSP'. For this screening status, the screening unit to which the case should be assigned had to be carefully considered. If the woman lived in the same screening unit catchment area from six months before diagnosis until death or until three years after the upper age limit for screening, then this screening unit was the one to which she was assigned. It was accepted that six months could elapse between the woman moving into an area and registering with a new GP in a different primary care trust. If the only record found for the woman was within six months of diagnosis, then the case was assigned to a screening unit as if the record had been in place at diagnosis. If a woman moved within a month of diagnosis but was unlikely to have been screened by the new screening unit (e.g. moved to a hospice shortly before death) then the case was assigned to the first screening unit.
Data validation
The data validation process is summarized in Figure 2 . Initially the screening status table was checked to resolve invalid entries and typographical errors. In particular, it was verified that all cases had a screening status and were assigned to a screening unit. Numerous validation checks were then carried out on all cases looking for age and time interval anomalies.
RESULTS
Overall, the West Midlands breast screening status algorithm enabled a screening status to be assigned to 14,680 (96%) of the 15,316 malignant primary breast cancers to which it was applied, leaving 636 unresolvable queries. The distribution of the cancers between the eight screening status classifications is summarized in Table 2 . In total, 6436 screen-detected cancers were identified. These made up the largest proportion of cases (42%) in a single screening status classification. In all, 5652 screen-detected cancers were matched to the cancer registration database using the automated matching process based on surname, forename initial, year of birth and sex ( Table 3 ). The remaining 784 cancers had to be manually matched due to there being a partial match; a match to a tumour in a different time period or no match at all. Where this failed to find the screendetected breast cancer on the cancer registration database, further details were requested in writing from the screening units so that a new tumour could be registered, or an existing patient record could be amended. This manual matching exercise highlighted 110 screen-detected breast Figure 1 Screening status algorithm. Screening status classifications: AD, assessment defaulter; DBI, diagnosed before invitation; I, cancer following a negative screening result; LP, lapsed attender; NA, non-attender; SD, screen-detected; SDR, screendetected recurrence; SP, not screened, ceased, Unresolvables: ENI, incomplete NBSS episode; X, insufficient information to determine screening status; X1, address outside the West Midlands or c/o address; X2, relevant screen outside West Midlands; X3, resident in the West Midlands but not on a call/recall register cancers, which were not recorded on the cancer registration database (all of which have now been registered) and 120 screen-detected cancers which were recurrences of previous primaries.
In all, 4059 cases (26%) were cancers diagnosed following a negative screening result. This included cancers diagnosed within 36 months of the last screen (interval cancers), cancers diagnosed more than three years after the negative screen and cancers in women above the screening age band. The decision to include cancers diagnosed in women aged 50-64 more than three years after a negative screen in this group was made because some breast screening units do not always operate on a strict 36-month cycle. The characteristics of these cases will be examined separately in subsequent analyses when the assessment history, invasive status, age at last screen and time since last screen will be used to determine the number and proportion of interval cancers. These will be fed back to the screening units for validation before calculating interval cancer rates.
398 cancers (3%) were diagnosed in women who had not attended their most recent appointment (lapsed attenders). A total of 17 women defaulted the assessment process after receiving a positive screening result. The remaining 3770 cancers (25%) had not been screened prior to diagnosis, including 46 women who were ceased from the screening programme. 1520 cancers (10%) were diagnosed in nonattenders. For these cancers, the outcome of the most recent appointment will be taken into account to determine reasons for non-attendance of a screening invitation. 1939 cancers (13%) were diagnosed before the woman was invited for screening and 265 cases (2%) were not screened because they were not known to the NHSBSP. As expected, the majority of cancers in women not screened were diagnosed before 1994, when not all screening units had completed a full cycle of their catchment area.
DISCUSSION
This paper demonstrates that that the West Midlands breast screening status algorithm provides a robust tool for assigning a screening status to all breast cancers in the eligible Table1 Screening status categories 1 Screen-detected cancer (SD)
Histologically or cytologically confirmed breast cancer following an NHSBSP screening mammogram 2 Interval cancer following negative screening episode (I) Cancer in women whose most recent screening episode prior to diagnosis was attended and closed as routine recall. These women may have had either a negative screen or a positive screen followed by a negative assessment. This includes cancers diagnosed in the interval between screens, which may be longer than 36 months, and cancers diagnosed in women above the screening age band 3 Not screened -diagnosed before first invitation (DBI) Cancer in women who had not previously been invited by the NHSBSP and were diagnosed before invitation. The woman may or may not have attended her first invitation, and may have chosen to be ceased at her first invitation. Includes women who had not previously been invited but who self-referred into the screening programme following diagnosis 4 Non-attender (NA)
Cancer in women with screening episodes before diagnosis on the NBSS appointment module which were never attended 5 Lapsed attender (LP)
Cancer in women whose most recent screening episode had an invitation before diagnosis which was not attended, but there was previous invitation(s) attended prior to diagnosis 6 Not screened-ceased (SP)
Cancer in women who were ceased from the NHSBSP at time of diagnosis. If the relevant ceased episode on NBSS was open for longer than a day, the woman was considered to have been ceased on the day that the episode was closed on NBSS. This classification was also applied to women who were suspended from the NHSBSP at time of diagnosis. The practice of suspending a woman from screening has been phased out 4 7 Defaulter (AD)
Cancer in women whose screening episode prior to diagnosis did not conclude with a diagnosis of cancer or with the woman being placed on early recall or routine recall. In the small number of cases recorded, the woman had defaulted the assessment process, but this classification could also have been applied to a woman who defaulted after a technically inadequate screen 8 Not screened -not known to the NHSBSP (UN)
Cancer in women who were on a call/recall register in the West Midlands, but had no breast screening record at any of the breast screening units screening population. Women who receive invitations to screening close to their 50th birthdays were not included in this audit, but the algorithm could also have been applied in these instances. In total, 636 breast cancers (3%) were flagged as unresolvable queries. 178 of these were due to inconsistencies between the relevant episode in the NBSS clinical module and the dates in the NBSS appointments module. Approximately 30% of these cases were where the woman had moved in or out of the region between screens, and as a consequence her screening history could not be accurately ascertained. This may well mean that the number of interval cancers is being underestimated. On the other hand, because cancer following a negative screen is over inclusive (i.e. a women with cancer diagnosed aged 68 could have had her last invitation aged 62), this will inflate the interval cancer rate. When the data are analysed further, this issue, along with cancers diagnosed over 36 months when screening round length was prolonged, will be resolved on an individual basis. In addition to the 6436 screen-detected breast cancers identified, there were 120 screen-detected cancers matched to a recurrence of a primary tumour. These cases were classed as 'screen-detected recurrences' and were excluded from the main cohort. It is standard practice for screening services to record recurrences detected through screening as screendetected cancers. However, these cancers need to be excluded from further analyses (e.g. survival analysis) as they have very different prognosis to primary screen-detected breast cancers.
The breast screening status algorithm developed by the West Midlands breast screening QARC enabled a screening status to be allocated to 96% of the 15,316 cases to which it was applied. A validation process has been developed to ensure that the data set is robust and accurate. Once a screening record has been located on the breast screening unit computer system, the screening status algorithm depends only on the date of diagnosis and the outcomes assigned to screening episodes before or after diagnosis. This simplicity enables the algorithm to be used easily. The breast screening status algorithm is independent of age at diagnosis and time between diagnosis, and the relevant screening mammogram or screening invitation. These factors are added to the screening status data set in order to subdivide these broad categories once the classification is complete. The algorithm also enables the prevalent/incident status (whether the relevant screening mammogram was the woman's prevalent [first] or an incident [subsequent] screen) to be recorded.
The data-set obtained by applying the algorithm is a valuable resource for the evaluation and quality assurance of the NHSBSP in the West Midlands. Interval cancer rates can be calculated and the prognostic characteristics of screen-detected breast cancers can be compared with those of cancers diagnosed symptomatically. Incidence, mortality and survival statistics can be presented according to screening status and differences explained in terms of the prognostic characteristics of the cancers. The algorithm has been developed for use with the NBSS computer system, which is used in the majority of services in the NHSBSP. However, the methodology could be used to develop an algorithm to assign a screening status to cancers detected by other screening services using alternative computer systems or paper records.
